Skip to main content
AMRX
NASDAQ Life Sciences

Amneal Lifts 2026 Guidance as Q3 Revenue Climbs 10% to $863M

Tom Rudovsky · Reported by Wiseek News
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$20.2
Mkt Cap
$7.119B
52W Low
$10.06
52W High
$21.681
52W Position info
101% above low
Off High info
6.8% below high
Rel. Volume info
1.7× avg
Market data snapshot near publication time

AMRX has more than doubled off its 52-week low of $10.06.

Summary

Amneal raised full-year 2026 guidance to revenue of $3.15B-$3.25B after Q3 revenue grew 10% to $863M from $785M. Adjusted EBITDA jumped 30% to $207M and adjusted diluted EPS came in at $0.26, up 53% from $0.17, with profit growth outpacing revenue as gross profit rose and operating expenses fell. The adjusted strength sits against a GAAP net loss of $22M versus $2M of net income a year earlier, driven by Kashiv acquisition and integration costs and higher taxes — the same loss already reported this morning at 6 cents per share. Growth was broad in Affordable Medicines and Specialty, while AvKARE fell 17% against a prior-year launch. Management also flagged higher inventory needs in growth areas, tempering the operating cash flow outlook without giving updated figures.

At the time of this announcement, AMRX was trading at $20.20 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $7.1B. The 52-week trading range was $10.06 to $21.68. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

AMRX - Latest Insights

AMRX
Nov 17, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $21.12
Real-time Price: $21.48 info
Change: +$0.360 (+2%) info
Market Cap: $7.489B info
AMRX
Nov 09, 2026, 4:21 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $21.28
Real-time Price: $21.48 info
Change: +$0.200 (+0.94%) info
Market Cap: $7.489B info
AMRX
Nov 03, 2026, 6:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $20.23
Real-time Price: $21.48 info
Change: +$1.25 (+6%) info
Market Cap: $7.489B info
AMRX
Oct 23, 2026, 4:05 PM EDT
Filing Type: 8-K/A
Importance Score:
8
Price at Filing: $20.38
Real-time Price: $21.48 info
Change: +$1.10 (+5%) info
Market Cap: $7.489B info
AMRX
Sep 18, 2026, 4:01 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $18.71
Real-time Price: $21.48 info
Change: +$2.77 (+15%) info
Market Cap: $7.489B info